Kazan ars BioCryst Pharmaceuticals ORLADEYO iin stikrarl ... - Investing.com Trkiye
| AKGRT Stock | TRY 6.95 0.08 1.14% |
Under 62% of AK Sigorta's investor base is looking to short. The analysis of current outlook of investing in AK Sigorta AS suggests that many traders are alarmed regarding AK Sigorta's prospects. AK Sigorta's investing sentiment shows overall attitude of investors towards AK Sigorta AS.
AKGRT |
Kazan ars BioCryst Pharmaceuticals ORLADEYO iin stikrarl ... Investing.com Trkiye
Read at news.google.com
 |
AK Sigorta Fundamental Analysis
We analyze AK Sigorta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AK Sigorta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AK Sigorta based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
AK Sigorta is rated second in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AK Sigorta AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AK Sigorta stock to make a market-neutral strategy. Peer analysis of AK Sigorta could also be used in its relative valuation, which is a method of valuing AK Sigorta by comparing valuation metrics with similar companies.
Peers
AK Sigorta Related Equities
| ISMEN | Is Yatirim | 1.48 | ||||
| TOASO | Tofas Turk | 1.47 | ||||
| AKGRT | AK Sigorta | 1.14 | ||||
| AKSA | Aksa Akrilik | 5.00 |
Complementary Tools for AKGRT Stock analysis
When running AK Sigorta's price analysis, check to measure AK Sigorta's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AK Sigorta is operating at the current time. Most of AK Sigorta's value examination focuses on studying past and present price action to predict the probability of AK Sigorta's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AK Sigorta's price. Additionally, you may evaluate how the addition of AK Sigorta to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |